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Introduction
Chronic recurrent multifocal osteomyelitis (CRMO) is a
rare form of chronic nonbacterial osteomyelitis of
unknown etiology and, to date, there is no uniformly
effective treatment for this disease. Role of magnetic
resonance imaging (MRI) to detect lesions in CRMO
has increased last years.
Objectives
To describe a patient affected by an atypical clinical
form of CRMO refractory to treatment who finally
responded to combination therapy with Etanercept
(ETN) and Methotrexate (MTX).
Methods
A 5-year-old boy presented with a 1 year history of right
leg pain with limited range of motion and difficulty in
walking due to flexion, abduction and external rotation
of right hip attitude. No fever. Plain radiographs were
normal. In the blood test, elevation of acute phase reac-
tants was detected: ESR 41 mm/h, CRP 2.27 mg/dL.
A Whole Body MRI (WB-MRI) scan revealed osteitic
multifocal lesions with edema and enhanced T2 signal
without necrosis in: proximal epiphysis and metaphysis
of right hip, proximal metaphysis of left femur, left
isquium, left acetabular bottom, right acetabulum,
sacrum and proximal metaphysis of right tibia. Intense
bilateral sacroiliitis and mild synovitis in right hip were
also observed. All this findings were suggestive of
CRMO. Synovium biopsy showed chronic synovitis. Bone
biopsy of femoral neck lesion was anatomopathologically
compatible with CRMO with signs of acute
inflammation. Cultures of both samples and synovial
fluid were negatives. No infection or malignancy was
identified in the extended study confirming the diagnosis
of CRMO.
Results
He received several courses of intravenous and oral anti-
biotics without improvement. NSAID regimen was inef-
fective too. Intravenous Pamidronate was initiated
adding oral prednisone and Methotrexate 15 mg/m2/
week sc to treatment. Twelve months later he had
improved pain and motion but persisted elevation of
ESR and CRP, a slightly limitation of right hip rotation
and he reported inflammatory back pain with 1 hour of
daily morning stiffness. A new MRI scan of the spine
was performed revealing inflammatory lesions in D10,
D11 and D12 vertebral pedicles suggestive of multiple
osteomyelitis foci. Etanercept 0.8 mg/kg/week was pre-
scribed concomitantly with Methotrexate. One month
after treatment initiation he reported improvement,
without back pain, and six months later he remained
symptom-free leading a normal life, with normal activ-
ity, without joint limitation of the hip during the physi-
cal examination and with normal acute phase reactants
in blood tests. The last MRI performed to control the
patient’s evolution revealed resolution of previous
lesions without inflammatory osteo-articular activity.
Conclusion
We suggest that anti-TNF therapies could be an effective
treatment option in some patients with CRMO refractory
to conventional treatment. Randomized controlled trials
are needed to establish the role of these therapies in
refractory CRMO. We also suggest that MRI is a useful
tool in diagnosis and follow up of CRMO patients,
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